West Pharmaceutical Services Inc.

WST | NYSE

$411.47

-$1.15 (-0.28%)

Nov 2, 2026, 12:36 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
PE Ratio	40.28	48.53	44.07	29.87	52.70	60.54
PEG Ratio	33.99	-3.13	31.57	-2.61	0.58	1.40
PS Ratio	6.47	8.27	8.87	6.07	12.33	9.75
PB Ratio	6.26	8.91	9.08	6.52	14.94	11.29
P/FCF Ratio	42.42	86.51	63.12	39.85	105.55	70.23
P/OCF Ratio	26.35	36.60	33.69	24.19	59.75	44.31
OCF/S Ratio	24.56	22.59	26.31	25.09	20.63	22.01
Debt / Equity Ratio	0.13	0.11	0.11	0.12	0.14	0.18
Quick Ratio	2.34	2.11	2.24	2.90	2.30	2.09
Current Ratio	3.02	2.79	2.88	3.70	2.93	2.73
Asset Turnover	0.72	0.79	0.77	0.80	0.85	0.77
Interest Coverage	1.03K	205.03	80.78	100.46	89.26	49.29
Return on Equity	15.54%	18.37%	20.60%	21.82%	28.34%	18.67%
Return on Assets	11.56%	13.52%	15.50%	16.20%	19.97%	12.39%
Return on Invested Capital	13.62%	15.69%	17.81%	20.49%	23.54%	15.04%
Dividend Yield	0.31%	0.25%	0.22%	0.31%	0.15%	0.23%
Payout Ratio	12.40%	12%	9.61%	9.23%	7.72%	13.89%
FCF Payout Ratio	13.75%	22.93%	14.57%	13.01%	17.43%	18.21%
Gross Profit Margin	35.89%	34.65%	38.38%	39.47%	41.45%	35.77%
Net Profit Margin	16.06%	17.03%	20.11%	20.30%	23.38%	16.13%
Pretax Profit Margin	20.02%	20.75%	24.25%	24.28%	27.17%	19.50%
Operating Profit Margin	20.09%	20.56%	24.09%	26.46%	26.80%	19.52%
FCF Margin	15.26%	9.56%	14.05%	15.23%	11.68%	13.89%
EBITDA Margin	25.07%	25.71%	28.60%	28.01%	31.08%	24.17%